Koch Industries

Photo
19.12.2023 • News

OCI to Sell Iowa Fertilizer Stake to Koch for $3.6 Billion

Dutch fertilizer and industrial chemicals group OCI Global has agreed to sell 100% of its equity interests in its US nitrogen fertilizer facility Iowa Fertilizer Company (IFCO), located in Wever, Iowa, to Koch Ag & Energy Solutions (KAES) for $3.6 billion.

Photo
30.11.2022 • News

Invista Breaks Ground on US Nylon Expansion

To help supply the expanding global demand for PA 6.6, which it markets as Nylon, US-based trademark owner Invista, now part of Koch Industries, is building a new plant at its Camden, South Carolina, production site, where groundbreaking ceremonies were recently held.

Photo
16.09.2022 • News

Koch and Ioniqa Partner on PET Recycling Technology

Koch Technology Solutions, the licensing arm of Koch Engineered Solutions, is partnering Ioniqa Technologies, a Dutch clean-tech spinoff from the Eindhoven University of Technology, to scale up and commercialize the latter’s advanced PET recycling process.

Photo
06.07.2022 • News

Koch Takes OCP’s Stake in Jorf Fertilizers

US-based Koch Ag & Energy Solutions (KAES) has acquired a 50% stake in Jorf Fertilizers Company III (JFC III) from Moroccan phosphates and fertilizer giant OCP and at the same time established a 50:50 joint venture with OCP.

Photo
14.04.2021 • News

Compass Minerals Sells Assets to ICL, Koch

Compass Minerals, a US producer of minerals and plant nutrition products, has finalized two separate sale agreements with ICL and Koch Agronomic Services for its South American and North American businesses, respectively. The deals follow a detailed analysis by Compass Minerals of its portfolio.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.